and Human Services (HHS)
EXPIRED
Participating Organization(s) |
National Institutes of Health (NIH) |
National Institute on Deafness and Other Communication Disorders (NIDCD) |
|
Funding Opportunity Title |
NIDCD Small Grant Program (R03) |
Activity Code |
R03 Small Grant Program |
Announcement Type |
Reissue of PAR-10-055 |
Related Notices
|
|
Funding Opportunity Announcement (FOA) Number |
PAR-13-057 |
Companion Funding Opportunity |
Not Applicable |
Only one NIDCD Small Grant application may be submitted by a PD/PI per due date. Applicants will be considered ineligible for this funding opportunity if they submit an NIDCD R01 or R21 application for the same review cycle that the NIDCD Small Grant application is submitted. See Section III. 3. Additional Information on Eligibility. |
|
Catalog of Federal Domestic Assistance (CFDA) Number(s) |
93.173 |
Funding Opportunity Purpose |
The NIDCD Small Grant Program (R03) is intended to support basic and clinical research of scientists who are beginning to establish an independent research career. It cannot be used for thesis or dissertation research. The research must be focused on one or more of the areas within the biomedical and behavioral scientific mission of the NIDCD: hearing, balance, smell, taste, voice, speech, or language. The NIDCD R03 grant mechanism supports different types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; translational research; outcomes research; and development of new research technology. Irrespective of the type of project, the intent of the NIDCD R03 is for the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s) to obtain sufficient preliminary data for a subsequent R01 application. |
Posted Date |
December 18, 2012 |
Open Date (Earliest Submission Date) |
January 26, 2013 |
Letter of Intent Due Date(s) |
Not Applicable |
Application Due Date(s) |
February 26, 2013; June 26, 2013; (Extended to November 1, 2013 per NOT-OD-14-003), Originally October 18, 2013; February 26, 2014; June 26 2014; October 28, 2014; February 26, 2015; June 26, 2015; October 28, 2015, by 5:00 PM local time of applicant organization. |
AIDS Application Due Date(s) |
Not Applicable |
Scientific Merit Review |
Standard dates apply. |
Advisory Council Review |
Standard dates apply. |
Earliest Start Date |
Standard dates apply. |
Expiration Date |
October 29, 2015 |
Due Dates for E.O. 12372 |
Not Applicable |
Required Application Instructions
It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide, except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.
Part 1. Overview Information
Part 2. Full Text of the Announcement
Section I. Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission
Information
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information
The NIDCD Small Grant (R03) program supports both basic and clinical scientists in the process of transitioning to independent investigator status. The expected outcome from projects funded under this mechanism is the acquisition of necessary preliminary data for a subsequent R01 application.
The NIDCD Small Grant is different from other NIH Small Grant Programs (R03). It is intended for clinical and basic scientists who are beginning to transition to independent researcher status. The PD(s)/PI(s) must be no more than 7 years beyond the date that the first professional, advanced professional, or terminal academic degree was awarded; whichever is most recent. Years of clinical training are excluded from this 7 year limit (see SECTION III. Eligibility Information). The NIDCD Small Grant Program is designed to support research that is likely to lead to a subsequent research project grant (R01) application. The research should be focused on one or more of the areas within the biomedical and behavioral scientific mission of the NIDCD, specifically: hearing, balance, smell, taste, voice, speech, or language.
The PD/PI may be in late-stage postdoctoral status still in his/her mentor's laboratory. However, there should be a clear commitment to the provision of laboratory space and a clear indication that a transition away from the mentor is being initiated and that the research project will be transferable.
Preliminary data are not required. However, the applicant PD/PI should provided sufficient information to give confidence to the reviewers that the proposed work is feasible and that data derived from the project would likely be suitable as preliminary data for a subsequent R01 application. Of course, if preliminary data are available it is advisable that these be included.
The proposed project may or may not be hypothesis-driven since the goal is to collect the necessary preliminary data sufficient to apply for an R01 grant. The project may aid in the formulation of hypotheses and may be milestone-driven or descriptive in scope.
The NIDCD Small Grant may be used by beginning clinician-scientists planning to make future application for an NIDCD mentored research career development award (K-award) to demonstrate the feasibility of the research to be proposed in their K-award application. Furthermore, as per NIH policy (http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-08-065.html), during the last two years of a mentored K-award, awardees may reduce their effort on the K-award to no less than 50% (6 person-months) in order to become PD/PI on a research project grant, including the NIDCD R03. The PD/PI’s total level of effort must remain at 75% (9 person-months) or more across the K-award and the R03 award. Questions regarding eligibility should be addressed prior to beginning to prepare the application by contacting the training staff member listed in Section VII. Agency Contacts.
Funding Instrument |
Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity. |
Application Types Allowed |
New The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. |
Funds Available and Anticipated Number of Awards |
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. |
Award Budget |
Applications may be submitted for up to $100,000 Direct Costs per year (i.e. the equivalent of four modules of $25,000 each) for up to three years of support. Consortium/contractual F&A costs are not included in the Direct Cost limit. F&A costs may be requested in addition to the $100,000/year Direct Cost limit. An NIDCD Small Grant (R03) will not be awarded to the same PI during the same Council round as another NIH Research Project grant is awarded. |
Award Project Period |
The scope of the proposed project should determine the project period. The maximum period of support is 3 years. |
NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made in response to this FOA.
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Governments
Other
Non-domestic (non-U.S.) Entities (Foreign Institutions) are
not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible
to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Applicant organizations must complete the following registrations as described in the SF424 (R&R) Application Guide to be eligible to apply for or receive an award. Applicants must have a valid Dun and Bradstreet Universal Numbering System (DUNS) number in order to begin each of the following registrations.
All Program Directors/Principal Investigators (PD(s)/PI(s))
must also work with their institutional officials to register with the eRA
Commons or ensure their existing eRA Commons account is affiliated with the eRA
Commons account of the applicant organization.
All registrations must be completed by the application due date. Applicant
organizations are strongly encouraged to start the registration process at least
6 weeks prior to the application due date.
Any individual(s) with the skills, knowledge, and resources
necessary to carry out the proposed research as the Program Director(s)/Principal
Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to
develop an application for support. Individuals from underrepresented racial
and ethnic groups as well as individuals with disabilities are always
encouraged to apply for NIH support.
For institutions/organizations proposing multiple PDs/PIs, visit the Multiple
Program Director/Principal Investigator Policy and submission details in the Senior/Key
Person Profile (Expanded) Component of the SF424 (R&R) Application Guide. All
PDs/PIs of a multi-PD/PI application must meet the NIDCD Small Grant (R03)
eligibility criteria.
The PD/PI must be a U.S. citizen, permanent resident or valid U.S. visa holder. The PD/PI must be no more than 7 years beyond the date that the first professional, advanced professional, or terminal academic degree was awarded, whichever is most recent. The application receipt date will be used as the basis for determining the 7 year eligibility. Only one NIDCD Small Grant application may be submitted by a PD/PI per due date. Applicants will be considered ineligible for this opportunity if they submit an NIDCD R01 or R21 application for the same review cycle that the NIDCD Small Grant application is submitted.
Individuals who have served as PD/PI on any NIH research grant (including SBIR/STTR, subprojects of program project or center grants) or any other federally-funded research grant (e.g., NSF, DOE, VA) are NOT eligible for the NIDCD Small Grant Program. However, former recipients of Federally-funded National Research Service Award fellowships and traineeships (i.e. F- and T- series awards) or mentored career development awards (i.e. K awards) are eligible for the NIDCD Small Grant program. Recipients of the K99/R00 award are not eligible to apply for the NIDCD R03. The PD/PI must be no more than 7 calendar years beyond the date the terminal degree was awarded. Formal years of clinical training (Internship, Residency, and Fellowship) are not counted as part of the 7 year limit. In addition, exemption of years for clinical training is not limited to physicians. For example, individuals with clinical training in Medical Genetics, Audiology, or Speech-Language Pathology are also eligible for the exemption. The PD/PI may still be in late-stage postdoctoral status and housed in their mentor's laboratory. However, there should be a clear commitment to the provision of laboratory space and a clear indication that a transition away from the mentor is being initiated and that the research project will be transferable. These factors should be addressed in an accompany letter from the mentor (see Section IV.2. for details on how to submit the letter). Questions regarding eligibility should be addressed prior to beginning to prepare the application by contacting the appropriate staff member listed in Section VII. Agency Contacts.
This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.
Applicant organizations may submit more than one application, provided that each application is scientifically distinct.
NIH will not accept any application that is essentially the same as one already reviewed within the past thirty-seven months (as described in the NIH Grants Policy Statement), except for submission:
Only one NIDCD Small Grant (R03) application may be submitted by a PD/PI per receipt date. PD/PIs who successfully obtain an NIDCD Small Grant award are not eligible for another NIDCD R03.
An NIDCD (R03) Small Grant will not be awarded to the same PI during the same Council round that another NIH Research Project grant is awarded.
Applicants must download the SF424 (R&R) application package associated with this funding opportunity using the Apply for Grant Electronically button in this FOA or following the directions provided at Grants.gov.
It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide, except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
For information on Application Submission and Receipt, visit Frequently Asked Questions Application Guide, Electronic Submission of Grant Applications.
The forms package associated with this FOA includes all applicable components, mandatory and optional. Please note that some components marked optional in the application package are required for submission of applications for this FOA. Follow all instructions in the SF424 (R&R) Application Guide to ensure you complete all appropriate optional components.
All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.
Other Attachments
Those PD/PIs who are in late-stage postdoctoral status and housed in their mentor's laboratory should submit documentation from their mentor indicating a clear commitment to the provision of laboratory space and a clear indication that a transition away from the mentor is being initiated and that the research project will be transferable. This document should be included in the Other Attachments field in the SF424 (R&R) Other Project Information Component.
Those PD(s)/PI(s) with formal years of clinical training who wish to have those years excluded from the 7 year limit for eligibility should document those years of clinical training in their Biographical Sketch. The date (mm/dd/yyyy) the terminal degree was awarded, as well as specific dates of clinical training (from mm/dd/yyyy to mm/dd/yyyy), should be specified in the PD/PI’s Biographical Sketch.
All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:
Resource Sharing Plan
Individuals are required to comply with the instructions for the Resource Sharing Plans (Data Sharing Plan, Sharing Model Organisms, and Genome Wide Association Studies (GWAS)) as provided in the SF424 (R&R) Application Guide, with the following modifications:
Appendix
Do not use the Appendix to circumvent page limits. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide, with the following modifications:
Part I. Overview Information contains information about Key Dates. Applicants are encouraged to submit applications before the deadline to ensure they have time to make any application corrections that might be necessary for successful submission.
Organizations must submit applications via Grants.gov, the online portal to find and apply for grants across all Federal agencies. Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration.
Applicants are responsible for viewing their application before the deadline in the eRA Commons to ensure accurate and successful submission.
Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide.
This initiative is not subject to intergovernmental review.
All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Pre-award costs are allowable only as described in the NIH Grants Policy Statement.
Applications must be submitted electronically following the instructions described in the SF424 (R&R) Application Guide. Paper applications will not be accepted.
Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.
For assistance with your electronic application or for more information on the electronic submission process, visit Applying Electronically.
Important
reminders:
All PD(s)/PI(s) must include their eRA Commons ID in the
Credential field of the Senior/Key Person Profile Component of the
SF424(R&R) Application Package. Failure to register in the Commons
and to include a valid PD/PI Commons ID in the credential field will prevent
the successful submission of an electronic application to NIH.
The applicant organization must ensure that the DUNS number it provides on the application
is the same number used in the organization’s profile in the eRA Commons and
for the System for Award Management (SAM). Additional information may be found
in the SF424 (R&R) Application Guide.
See more
tips for avoiding common errors.
Upon receipt, applications will be evaluated for completeness by the Center for Scientific Review, NIH. Applications that are incomplete will not be reviewed.
Applicants are required to follow the instructions for post-submission materials, as described in NOT-OD-10-115.
Only the review criteria described below will be considered in the review process. As part of the NIH mission, all applications submitted to the NIH in support of biomedical and behavioral research are evaluated for scientific and technical merit through the NIH peer review system.
For this particular announcement, note the following:
The NIDCD R03 small grant is a mechanism for supporting discrete, well-defined projects that realistically can be completed in three years and that require limited levels of funding. Because the Research Strategy component is restricted to 6 pages (does not include the 1 page Specific Aims), a small grant application will not have the same level of detail or extensive discussion found in an R01 application. Accordingly, reviewers should evaluate the conceptual framework and general approach to the problem, placing less emphasis on methodological details and certain indicators traditionally used in evaluating the scientific merit of R01 applications, including supportive preliminary data. Appropriate justification for the proposed work can be provided through literature citations, data from other sources, or from investigator-generated data. Preliminary data are not required, particularly in applications proposing pilot or feasibility studies. However, the PD/PI should provide sufficient information to give confidence to the reviewers that the proposed work is feasible and that data derived from the project would likely be suitable as pilot data for a subsequent R01 application. Of course, if preliminary data are available it is advisable that these be included.
Finally, the NIDCD R03 program is intended for investigators who are in the beginning stages of establishing an independent research career and who have not served as PD/PI on any federally funded grant except as described in Section III, 1.B. Eligible Individuals above. These PD/PIs are not expected to have the grant writing experience as a more senior R01 funded investigator.
Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).
Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.
Significance
Does the project address an important problem or a critical barrier to progress in the field? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
Investigator(s)
Are the PD(s)/PI(s), collaborators, and other researchers well suited to the project? If Early Stage Investigators or New Investigators, or in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project?
Innovation
Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?
Approach
Are the overall strategy, methodology, and analyses
well-reasoned and appropriate to accomplish the specific aims of the project?
Are potential problems, alternative strategies, and benchmarks for success
presented? If the project is in the early stages of development, will the
strategy establish feasibility and will particularly risky aspects be
managed?
If the project involves clinical research, are the plans for 1) protection of
human subjects from research risks, and 2) inclusion of minorities and members
of both sexes/genders, as well as the inclusion of children, justified in terms
of the scientific goals and research strategy proposed?
Environment
Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?
As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact score, but will not give separate scores for these items.
Protections for Human Subjects
For research that involves human subjects but does
not involve one of the six categories of research that are exempt under 45 CFR
Part 46, the committee will evaluate the justification for involvement of human
subjects and the proposed protections from research risk relating to their
participation according to the following five review criteria: 1) risk to
subjects, 2) adequacy of protection against risks, 3) potential benefits to the
subjects and others, 4) importance of the knowledge to be gained, and 5) data
and safety monitoring for clinical trials.
For research that involves human subjects and meets the criteria for one or
more of the six categories of research that are exempt under 45 CFR Part 46,
the committee will evaluate: 1) the justification for the exemption, 2) human
subjects involvement and characteristics, and 3) sources of materials. For
additional information on review of the Human Subjects section, please refer to
the Human
Subjects Protection and Inclusion Guidelines.
Inclusion of Women, Minorities, and Children
When the proposed project involves clinical research, the committee will evaluate the proposed plans for inclusion of minorities and members of both genders, as well as the inclusion of children. For additional information on review of the Inclusion section, please refer to the Human Subjects Protection and Inclusion Guidelines.
Vertebrate Animals
The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following five points: 1) proposed use of the animals, and species, strains, ages, sex, and numbers to be used; 2) justifications for the use of animals and for the appropriateness of the species and numbers proposed; 3) adequacy of veterinary care; 4) procedures for limiting discomfort, distress, pain and injury to that which is unavoidable in the conduct of scientifically sound research including the use of analgesic, anesthetic, and tranquilizing drugs and/or comfortable restraining devices; and 5) methods of euthanasia and reason for selection if not consistent with the AVMA Guidelines on Euthanasia. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.
Biohazards
Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.
Resubmissions
For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.
Renewals
Not Applicable
Revisions
Not Applicable
As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.
Applications from Foreign Organizations
Not Applicable
Select Agent Research
Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).
Resource Sharing Plans
Reviewers will comment on whether the following Resource Sharing Plans, or the rationale for not sharing the following types of resources, are reasonable: 1) Data Sharing Plan; 2) Sharing Model Organisms; and 3) Genome Wide Association Studies (GWAS).
Budget and Period of Support
Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.
Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s) convened by NIDCD, in accordance with NIH peer review policy and procedures, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.
As part of the scientific peer review, all applications:
Applications will be assigned on the basis of established PHS referral guidelines to the appropriate NIH Institute or Center. Applications will compete for available funds with all other recommended applications submitted in response to this FOA. Following initial peer review, recommended applications will receive a second level of review by the NDCD Advisory Council. The following will be considered in making funding decisions:
After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons.
Information regarding the disposition of applications is available in the NIH Grants Policy Statement.
If the application is under consideration for funding, NIH
will request "just-in-time" information from the applicant as
described in the NIH Grants
Policy Statement.
A formal notification in the form of a Notice of Award (NoA) will be provided
to the applicant organization for successful applications. The NoA signed by
the grants management officer is the authorizing document and will be sent via
email to the grantee’s business official.
Awardees must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection
of an application for award is not an authorization to begin performance. Any
costs incurred before receipt of the NoA are at the recipient's risk. These
costs may be reimbursed only to the extent considered allowable pre-award costs.
Any application awarded in response to this FOA will be subject to the DUNS, SAM
Registration, and Transparency Act requirements as noted on the Award
Conditions and Information for NIH Grants website.
All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities. More information is provided at Award Conditions and Information for NIH Grants.
Cooperative Agreement Terms and Conditions of Award
Not Applicable
When multiple years are involved, awardees will be required to submit the annual Non-Competing Progress Report (PHS 2590 or RPPR) and financial statements as required in the NIH Grants Policy Statement.
A final progress report, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the NIH Grants Policy Statement.
The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All awardees of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over $25,000. See the NIH Grants Policy Statement for additional information on this reporting requirement.
We encourage inquiries concerning this funding opportunity
and welcome the opportunity to answer questions from potential applicants.
Grants.gov
Customer Support (Questions regarding Grants.gov registration and
submission, downloading or navigating forms)
Contact Center Phone: 800-518-4726
Email: [email protected]
GrantsInfo (Questions regarding application instructions and
process, finding NIH grant resources)
Telephone 301-710-0267
TTY 301-451-5936
Email: [email protected]
eRA Service Desk (Questions regarding ASSIST, eRA Commons registration, tracking application status, post submission issues)
Phone: 301-402-7469 or 866-504-9552 (Toll Free)
TTY: 301-451-5939
Email: [email protected]
For
general and eligibility questions, contact:
Dr. Bracie Watson, Jr.
Division of Scientific Programs
6120 Executive Blvd, Suite 400C
Bethesda, MD 20892
Telephone: (301) 402-3458
Fax: (301) 402-6251
Email: [email protected]
For questions regarding scientific issues:
Epidemiology, Population-Based Research, and Biostatistics:
Mr. Howard J. Hoffman
Telephone: (301) 402-1843
Email: [email protected]
Hearing
and Balance/Vestibular:
Dr. Janet Cyr
Peripheral pathways, presbycusis, noise-induced
hearing loss
Telephone: (301) 402-3458
Email: [email protected]
Dr. Amy Donahue
Clinical assessment and management
Psychoacoustics, cochlear implants
Telephone: (301) 402-3458
Email: [email protected]
Dr. Nancy Freeman
Molecular and developmental biology, signal
transduction
Telephone: (301) 402-3458
Email: [email protected]
Dr. Roger L. Miller
Auditory and other neural prostheses, tinnitus
Telephone: (301) 402-3464
Email: [email protected]
Dr. Christopher Platt
Central pathways, temporal bone
Telephone: (301) 402-3458
Email: [email protected]
Dr. Bracie Watson, Jr.
Genetics, otitis media, immune mediated disorders
Telephone: (301) 402-3458
Email: [email protected]
Language:
Dr. Judith CooperResearch Training:
Dr. Daniel SklareDr. Melissa Stick
Scientific Review Branch
Division of Extramural Activities
National Institute on Deafness and Other Communication
Disorders
6120 Executive Blvd., EPS 400C
Bethesda, MD 20892-7180
Telephone: (301) 496-8683
Fax: (301) 402-6250
Email: [email protected]
Mr. Christopher Myers
Grants Management Branch
Division of Extramural Activities
National Institute on Deafness and Other Communication
Disorders
6120 Executive Blvd., EPS 400B, MSC-7180
Bethesda, MD 20892-7180
Telephone: (301) 435-0713
Fax: (301) 451-5370
Email: [email protected]
Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Parts 74 and 92.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
|
Department of Health and Human Services (HHS) |
|
|||
|
NIH... Turning Discovery Into Health® |
||||||